These results suggest an overall decrease of the memory B cell compartment in the patient circulation, with reduced class-switched and IgD+IgM+ memory B cell populations, alongside increased antibody secreting plasmablast subsets in the peripheral blood of stage IV patients with melanoma. The gene discussed is CD40LG; the disease is melanoma.